➡ Upstream Target
alzheimers
✗ KILL CRITERIA
- Loss-of-function variants in C1QA do not reduce AD risk in large GWAS
- Conditional knockout of C1QA in rodents does not reduce amyloid/tau burden
- Phase II trial targeting C1QA pathway shows no signal on primary cognitive endpoint